S&P 5007,675.92▼0.4% Nasdaq26,749.30▼0.7% Dow51,245.74▼0.5% Russell 2K2,826.40▼0.4% 10-Yr5.12%+1bp VIX15.69+0.51 WTI$95.27▲3.4% Gold$4,292.50▼0.6% EUR/USD1.138▼0.6% BTC$84,310▼0.1% Nikkei65,514▲0.8%
At close · Thu, Sep 24, 2026
Daily Market Updates.

Earnings

Home›Earnings›Previews›Eli Lilly price target raised after beat-and-raise qua…

Eli Lilly price target raised after beat-and-raise quarter

CNBC Earnings said strength in the company’s GLP-1 business indicates the stock may have further upside.

Reported · Written up by our desk · Previews

Eli Lilly’s stock price target was increased following another beat-and-raise quarter, according to CNBC Earnings.

The outlet pointed to ongoing strength in the company’s GLP-1 business, arguing it suggests the shares still have more room to run.

The update frames the latest results as confirmation of momentum in Eli Lilly’s GLP-1 franchise.

← Newer storyTreasuries hold steady after ISM impact, fuel prices steady

More like this

EarningsCat owners boost spending even as dog demand cools
EarningsRestaurant stocks hover near 52-week lows amid weaker US traffic
EarningsMicron earnings next week put focus on customer deals and buybacks
EarningsMeta subscriptions and Muse lift shares, with Instagram IAP surge
EarningsNewAmsterdam Pharma wins European approval for cholesterol drugs

Sources

CNBC EarningsWe're increasing our Eli Lilly price target after another beat-and-raise quarter

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.